# Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

> **NCT03934606** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 1488 (actual)

## Conditions studied

- Pancreas Cancer
- Prostate Cancer
- Hereditary Cancer
- Genetic Predisposition to Disease

## Interventions

- **BEHAVIORAL:** Genetic testing for hereditary predisposition

## Key facts

- **NCT ID:** NCT03934606
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2025-01-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 1488 (ACTUAL)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03934606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03934606, "Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03934606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*